IP Library Granted Patent US 8,361,720
Granted Patent B2
US 8,361,720 · App. 12/946,737 · Granted Jan 29, 2013

Real time cleavage assay

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,361,720
App. No.
12/946,737
Granted
Jan 29, 2013
Kind
B2
Abstract

A cleavage-based real-time PCR assay method is provided. In general terms, the assay method includes subjecting a reaction mixture comprising a) PCR reagents for amplifying a nucleic acid target, and b) flap cleavage reagents for performing a flap cleavage assay on the amplified nucleic acid target to two sets of thermocycling conditions. No additional reagents are added to the reaction between said first and second sets of cycles and, in each cycle of the second set of cycles, cleavage of a flap probe is measured.

Claims (44)

1. A method of sample analysis comprising:

subjecting a reaction mixture comprising:

PCR reagents for amplifying a nucleic acid target, and

flap cleavage reagents for performing a flap cleavage assay on said nucleic acid target,

to the following thermocycling conditions:

a first set of 5-15 cycles of:

i. a first temperature of at least 90° C.;

ii. a second temperature in the range of 60° C. to 75° C.;

iii. a third temperature in the range of 65° C. to 75° C.; followed by:

a second set of 20-50 cycles of:

i. a fourth temperature of at least 90° C.;

ii. a fifth temperature that is at least 10° C. lower than said second temperature;

iii. a sixth temperature in the range of 65° C. to 75° C.;

wherein no additional reagents are added to said reaction between said first and second sets of cycles and, in each cycle of said second set of cycles, cleavage of a flap probe is measured.

2. The method of claim 1 , wherein said method comprises measuring cleavage of said flap probe while said reaction mixture is at said fifth temperature.

3. The method of claim 1 , wherein cleavage of said flap probe is measured by detecting fluorescence of said reaction mixture during each of said 20-50 cycles.

4. The method of claim 1 , wherein:

said PCR reagents comprise: a nucleic acid template; a first PCR primer, a second PCR primer, a thermostable polymerase, and nucleotides; and

said flap cleavage reagents comprise: an invasive oligonucleotide, a flap probe, a thermostable flap endonuclease and a FRET cassette,

wherein said first PCR primer and said invasive oligonucleotide have different nucleotide sequences.

5. The method of claim 1 , wherein:

said PCR reagents comprise: a nucleic acid template, a first PCR primer, a second PCR primer, a thermostable polymerase, and nucleotides; and

said flap cleavage reagents comprise: an invasive oligonucleotide, a flap probe, a flap endonuclease and a FRET cassette,

wherein said first PCR primer and said invasive oligonucleotide have the same nucleotide sequence.

6. The method of claim 5 , wherein said first PCR primer is present in said reaction mixture at the same concentration as the second PCR primer.

7. The method of claim 1 , wherein said fourth temperature is in the range 50° C. to 55° C.

8. The method of claim 1 , wherein said thermocycling conditions comprises a first set of 8-12 cycles.

9. The method of claim 1 , wherein said reaction mixture is of a volume in the range of 5 μl to 50 μl, and each of said first to sixth temperatures is, independently, of a duration in the range of 10 seconds to 3 minutes.

10. The method of claim 1 , wherein said second and third temperatures are the same temperature.

11. The method of claim 1 , wherein said method further comprises graphing the amount of cleavage that occurs at each of said second set of cycles, thereby providing an estimate of the abundance of said mutation in said nucleic acid target.

12. The method of claim 1 , wherein said flap cleavage assay detects a mutation in said nucleic acid target.

13. A device for performing sample analysis comprising:

a) a thermocycler programmed to perform the following thermocycling conditions:

a first set of 5-15 cycles of:

i. a first temperature of at least 90° C.;

ii. a second temperature in the range of 60° C. to 75° C.;

iii. a third temperature in the range of 65° C. to 75° C.; followed by:

a second set of 20-50 cycles of:

i. a fourth temperature of at least 90° C.;

ii. a fifth temperature that is at least 10° C. lower than said second temperature;

iii. a sixth temperature in the range of 65° C. to 75° C.; and

b) a vessel comprising:

PCR reagents for amplifying a nucleic acid target, and

flap cleavage reagents for performing a flap cleavage assay on said nucleic acid target.

Assignments (5)
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENT RIGHTS (REEL/FRAME 69898/0249) Recorded Mar 27, 2026
From: JPMORGAN CHASE BANK, N.A.
To: EXACT SCIENCES CORPORATION
Reel/Frame 075288/0393 →
PATENT SECURITY AGREEMENT Recorded Jan 14, 2025
From: EXACT SCIENCES CORPORATION
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 069898/0249 →
MERGER Recorded Nov 8, 2022
From: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
To: EXACT SCIENCES CORPORATION
Reel/Frame 061692/0163 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2017
From: EXACT SCIENCES CORPORATION
To: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
Reel/Frame 043997/0868 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 2, 2011
From: OLDHAM-HALTOM, REBECCA; ZOU, HONGZHI; LIDGARD, GRAHAM P.; DOMANICO, MICHAEL J.; ALLAWI, HATIM
To: EXACT SCIENCES CORPORATION
Reel/Frame 025735/0766 →